June 1, 1996Journal of Hypertension
Treatment guidelines in hypertension: current limitations and future solutions
Population
Patients with classical essential hypertension or isolated systolic hypertension up to the age of 85 years
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Guideline uncertainties on BP measurement, targets, and first-line agents warrant individualized caution; leaves open optimal regimens pending prospective randomized trials.
Key Points
- This research explores limitations in current hypertension treatment guidelines and suggests solutions for improvement.
- Review of national and international hypertension treatment guidelines.
- Analysis of the uncertainty in blood pressure measurement methods.
- Discussion of the choice of antihypertensive drugs and the necessity of future trials.
- No major trials confirming that newer antihypertensive drugs reduce morbidity and mortality.
- Emerging concerns about certain drug classes potentially increasing cardiovascular risks.
- Calls for more prospective randomized trials to ensure safe and effective hypertension treatments.
Structured PICO
P
Population
Patients with classical essential hypertension or isolated systolic hypertension up to the age of 85 years
I
Intervention
First-line antihypertensive drugs (diuretics, beta-blockers, ACE inhibitors, calcium antagonists, alpha-blockers)
This review highlights the consensus and uncertainties in hypertension guidelines, emphasizing the need for prospective randomized trials to clarify the optimal choice of first-line antihypertensive therapy.
Cite This Study
John Chalmers (1996) studied this question.